Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Patrys Limited ( (AU:PAB) ) just unveiled an update.
Patrys Limited has announced a successful capital raising of $358,362 through a placement of new shares to sophisticated and professional investors. This funding will support the company’s working capital and business development activities, particularly for its deoxymab program, until it receives an anticipated R&D rebate. Additionally, the company has made significant board changes, appointing Dr. Anton Uvarov as a non-executive director and Mr. Peter Christie as Chair, which may strengthen its strategic direction and governance.
More about Patrys Limited
Patrys Limited operates in the biotechnology industry, focusing on the development of novel antibody therapies. The company is particularly involved in advancing its deoxymab program, targeting innovative treatments in the healthcare sector.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.09M
Find detailed analytics on PAB stock on TipRanks’ Stock Analysis page.